Author: Reporter

Why some schools are trying to close growing racial gaps in math by teaching all kids the same classes

Hope Reed was seeing stark disparities a decade ago at her high school in the suburbs of Columbia, South Carolina. Nearly half the school’s students were White, but the freshman remedial math classes were made up of almost all students of color. Reed, then chair of the math department at Blythewood High School, intervened with an experiment. She taught a ninth-grade remedial class and used the regular Algebra 1 curriculum with nearly 50 students. They were honors students, and they were going to do honors work, she recalled telling them. At the end of the year, about 90% of...

Read More

LGBTQ+ activism: Black queer leaders rise to prominence in Congress after years of exclusion

On the 60th anniversary of the March on Washington this summer, a few Black queer advocates spoke passionately before the main program about the ongoing struggle for LGBTQ+ rights. As some of them got up to speak, the crowd was still noticeably small. Hope Giselle, a speaker who is Black and trans, said she felt the event’s programming echoed the historical marginalization and erasure of Black queer activists in the Civil Rights Movement. However, she was buoyed by the fact that prominent speakers drew attention to recent efforts to turn back the clock on LGBTQ+ rights, like the attacks...

Read More

Shifting political landscape: Why voters may face a Trump-Biden rematch in the 2024 election

The end of Labor Day weekend would typically mark the start of a furious sprint to the Iowa caucuses as candidates battle for their party’s presidential nomination. But as the 2024 campaign comes into greater focus, the usual frenzy is yielding to a sense of inevitability. Among Republicans, Donald Trump is dominating the primary field, outpacing rivals with resumes as governors, diplomats, and entrepreneurs that would normally prove compelling. The former president’s strength comes despite — or perhaps because of — multiple criminal indictments that threaten to overshadow any serious debate about the future of the country. And for...

Read More

Insurrection Act: Legacy law could allow a re-elected Trump to weaponize U.S. military against his enemies

Campaigning in Iowa this year, Donald Trump said he was prevented during his presidency from using the military to quell violence in primarily Democratic cities and states. Calling New York City and Chicago “crime dens,” the criminally indicted front-runner for the 2024 Republican presidential nomination told his audience, “The next time, I’m not waiting. One of the things I did was let them run it and we’re going to show how bad a job they do,” he said. “Well, we did that. We don’t have to wait any longer.” Trump has not spelled out precisely how he might use...

Read More

Zepbound: FDA approves new version of Eli Lilly’s Mounjaro diabetes drug to assist with weight loss

A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced in early November. The U.S. Food and Drug Administration approved Eli Lilly’s drug, named Zepbound. The drug, also known as tirzepatide, helped dieters lose as much as 40 to 60 pounds in testing. Zepbound is the latest diabetes drug approved for chronic weight management, joining Novo Nordisk’s Wegovy, a high-dose version of its diabetes treatment Ozempic. Both are weekly injections. The FDA approved Lilly’s drug for people who are considered obese, with a body mass index of 30 or higher,...

Read More

Despite little research the mind-altering drug ketamine has become a new treatment for pain

As U.S. doctors scale back their use of opioid painkillers, a new option for hard-to-treat pain is taking root: ketamine, the decades-old surgical drug that is now a trendy psychedelic therapy. Prescriptions for ketamine have soared in recent years, driven by for-profit clinics and telehealth services offering the medication as a treatment for pain, depression, anxiety and other conditions. The generic drug can be purchased cheaply and prescribed by most physicians and some nurses, regardless of their training. With limited research on its effectiveness against pain, some experts worry the U.S. may be repeating mistakes that gave rise to...

Read More